Specific phenotypes of heart failure with preserved/reduced ejection fraction according to Body Mass Index

被引:0
|
作者
Matsushita, Kenichi [1 ,2 ]
Harada, Kazumasa [1 ]
Jimba, Takahiro [1 ]
Kohno, Takashi [1 ]
Nakano, Hiroki [1 ]
Kitano, Daisuke [1 ]
Takei, Makoto [1 ]
Kohsaka, Shun [1 ]
Yoshino, Hideaki [1 ]
Yamamoto, Takeshi [1 ]
Nagao, Ken [1 ]
Takayama, Morimasa [1 ]
机构
[1] Tokyo CCU Network Sci Comm, Tokyo, Japan
[2] Saitama Med Univ, Int Med Ctr, Dept Cardiol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan
基金
日本学术振兴会;
关键词
Body Mass Index; Heart failure; diastolic; systolic; Obesity; Phenotype; OBESITY PARADOX; PHYSICAL-ACTIVITY; IMPACT; MORTALITY; RISK; PREVALENCE; MORBIDITY; COMMITTEE; DISEASE; FITNESS;
D O I
10.23736/S2724-5683.24.06633-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The relationship between Body Mass Index (BMI) and acute heart failure (HF) remains ill-defined. This study aimed to compare the influence of BMI on in-hospital mortality between patients with acute HF with preserved ejection fraction (HFpEF) and those with acute HF with reduced ejection fraction (HFrEF) and to examine the specific phenotypes of HFpEF/HFrEF according to BMI. METHODS: This multicenter retrospective study included 5313 and 6332 consecutive patients with acute HFpEF and HFrEF, respectively. Low, normal, and high BMIs were defined as BMI <18.5, 18.5 <= BMI <25.0, and BMI >= 25.0, respectively. Overweight/obesity was defined as BMI >= 25.0. Kaplan-Meier survival curves and log-rank tests were used for between-group comparisons of in-hospital mortality. Univariable and multivariable Cox regression analyses were performed to identify significant prognostic factors. RESULTS: A paradoxical association between overweight/obesity and survival benefits, the so-called obesity paradox exists in HFpEF (log-rank P<0.05 in low BMI vs. normal BMI, low BMI vs. high BMI, and normal BMI vs. high BMI). In HFrEF, a trend towards lower in-hospital mortality was observed in patients with higher BMI. However, the obesity paradox in patients with HFrEF was not as evident as that in patients with HFpEF. Significant differences in the clinical characteristics and prognostic factors for in-hospital mortality were observed among the groups according to BMI. CONCLUSIONS: The obesity paradox was more evident in patients with HFpEF than in those with HFrEF. Specific phenotypes of HFpEF and HFrEF according to BMI were revealed. (Cite this article as: Matsushita K, Harada K, Jimba T, Kohno T, Nakano H, Kitano D, et al. Specific phenotypes of heart failure with preserved/reduced ejection fraction according to Body Mass Index. Minerva Cardiol Angiol 2025 Feb 27. DOI: 10.23736/S2724-5683.24.06633-X)
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Curative effect analysis of urapidil on heart failure with preserved ejection fraction and heart failure with reduced ejection fraction
    Yuan, Xiao-Ye
    Ding, Cun-Tao
    Li, Jing
    Tan, Jing
    Wang, Yan-Ling
    Fan, Zhen-Xing
    He, Jing-Yu
    Yang, Wei
    Hua, Qi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (01): : 494 - 503
  • [32] Statins Beneficial for Heart Failure With Preserved Ejection Fraction But Not Heart Failure With Reduced Ejection Fraction?
    Ohte, Nobuyuki
    Little, William C.
    CIRCULATION JOURNAL, 2015, 79 (03) : 508 - 509
  • [33] Management of Atrial Fibrillation Across the Spectrum of Heart Failure With Preserved and Reduced Ejection Fraction
    Reddy, Yogesh N., V
    Borlaug, Barry A.
    Gersh, Bernard J.
    CIRCULATION, 2022, 146 (04) : 339 - 357
  • [34] New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes
    Senni, Michele
    Paulus, Walter J.
    Gavazzi, Antonello
    Fraser, Alan G.
    Diez, Javier
    Solomon, Scott D.
    Smiseth, Otto A.
    Guazzi, Marco
    Lam, Carolyn S. P.
    Maggioni, Aldo P.
    Tschoepe, Carsten
    Metra, Marco
    Hummel, Scott L.
    Edelmann, Frank
    Ambrosio, Giuseppe
    Coats, Andrew J. Stewart
    Filippatos, Gerasimos S.
    Gheorghiade, Mihai
    Anker, Stefan D.
    Levy, Daniel
    Pfeffer, Marc A.
    Stough, Wendy Gattis
    Pieske, Burkert M.
    EUROPEAN HEART JOURNAL, 2014, 35 (40) : 2797 - 2811
  • [35] Management of patients with heart failure and preserved ejection fraction
    Jasinska-Piadlo, Alicja
    Campbell, Patricia
    HEART, 2023, 109 (11) : 874 - 883
  • [36] Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
    Kirkman, Danielle L.
    Bohmke, Natalie
    Billingsley, Hayley E.
    Carbone, Salvatore
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [37] Diagnosis of heart failure with preserved or reduced ejection fraction in a one-stop clinic
    Andrea, Rut
    Falces, Carlos
    Sanchis, Laura
    Sitges, Marta
    Heras, Magda
    Brugada, Josep
    ATENCION PRIMARIA, 2013, 45 (04): : 184 - 192
  • [38] Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity
    van Dalen, Bas M.
    Chin, Jie Fen
    Motiram, Praveen A.
    Hendrix, Anneke
    Emans, Mireille E.
    Brugts, Jasper J.
    Westenbrink, B. Daan
    de Boer, Rudolf A.
    CARDIOVASCULAR DIABETOLOGY, 2025, 24 (01)
  • [39] Effect of Mineralocorticoid Receptor Antagonists in Heart Failure with Preserved Ejection Fraction and with Reduced Ejection Fraction - A Nar-rative Review
    Mares, Adriana
    Rodriguez, Tayana
    Deoker, Abhizith
    Lehker, Angelica
    Mukherjee, Debabrata
    CURRENT VASCULAR PHARMACOLOGY, 2022, 20 (01) : 46 - 51
  • [40] Management of heart failure with reduced ejection fraction
    Haydock, Paul M.
    Flett, Andrew S.
    HEART, 2022, 108 (19) : 1571 - 1579